Diamondback Drugs is an exceptional company committed to providing superior care to pets and exceptional service to our customers. I am excited to join Mike Blaire and his team and to continue to expand the business.
Scottsdale, Arizona (PRWEB) December 08, 2015
Scottsdale, Arizona-based Diamondback Drugs is excited to announce the arrival of incoming President Fabian McCarthy.
Diamondback Drug's CEO Michael Blaire stated: “We are very pleased that Fabian will be coming on board as President. He has been working with us in a consulting relationship and I am certain his new role will benefit the company and our customers.”
With more than 30 years of experience in the healthcare industry, Mr. McCarthy’s experience is sure to be a valuable asset to the Diamondback Drugs family.
Prior to joining Diamondback, Mr. McCarthy served as the Executive VP of Operations at Freedom Innovations, a leading California prosthetics provider highly regarded by both prosthetists and patients.
Before serving at Freedom Innovations, Mr. McCarthy was the Executive VP of Operations and New Product Development at Aircast Incorporated, an orthopedic firm known for introducing innovative bracing, cold therapy, and vascular products to the orthopedic community.
When Aircast was acquired by DJO Global, Mr. McCarthy took on new challenges as General Manager of Aircast and Vice President of International Operations for DJO Global, overseeing the integration of Aircast into its new parent company. For the past ten years, Mr. McCarthy has also worked as an Operating Executive for Tailwind Capital, a private equity firm based in New York City with over two billion dollars in committed equity capital.
Mr. McCarthy specializes in lean manufacturing practices, and new product development. In addition to his wealth of leadership experience, he holds several patents on orthopedic devices.
Mr. McCarthy is eager to put his experience to good use as Diamondback Drug’s incoming President. On his new role, he had this to say: “Diamondback Drugs is an exceptional company committed to providing superior care to pets and exceptional service to our customers. I am excited to join Mike Blaire and his team and to continue to expand the business.”
Please join Diamondback Drugs in extending an enthusiastic welcome to Mr. Fabian McCarthy, and wishing him a smooth and enjoyable transition into his new role.
About Diamondback Drugs
Scottsdale, Arizona-based Diamondback Drugs is a portfolio company of Tailwind Capital and specializes in the art and science of veterinary compounding. They offer home delivery, and stock the widest range of medications, chemicals, bases and flavors. Learn more about Diamondback Drugs at their website: http://www.diamondbackdrugs.com/ or call them direct at 866-578-4420.